The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by ...

There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms and progression, ...

Insulin resistance (IR) is a crucial factor in metabolic disorders like non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS), ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients.

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in participants.

Interest in botanicals shows no signs of fading. According to Future Market Insights, the botanical ingredients market is ...

Tempus will use its "Lens" data analytics platform to analyze and restructure genomic data from the the Abrams Research Center.

The American Medical Association has established a new policy that aims to increase transparency and trust in AI tools used in clinical care. The policy was approved during the AMA’s annual meeting ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.